Pharmaceuticals

Eylea Market Thrives On Addressing The Rise In Ocular Diseases Is Supporting Development Across The Eylea Market

May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Eylea Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The eylea market size has shown strong expansion in recent years. It is projected to grow from $10.51 billion in 2025 to $11.15 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. This historical growth can be attributed to the rising prevalence of age-related macular degeneration, the aging global population, the strong clinical efficacy of anti-VEGF drugs, an increase in ophthalmology specialty centers, and supportive reimbursement for retinal therapies.

The eylea market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $14.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This growth throughout the forecast period stems from factors such as the increasing diabetic population, broadening applications for other retinal conditions, advancements in long-acting formulations, enhancements in drug delivery methods, and improved market access in developing regions. Key developments foreseen during this period encompass extended-interval anti-VEGF treatments, a move towards wider adoption of prefilled syringes, expanded application in diabetic retinopathy management, a rise in hospital-administered intravitreal procedures, and a heightened emphasis on real-world data and patient outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp

What Influential Factors Are Boosting The Eylea Market Demand?

The rising incidence of eye conditions is anticipated to boost the Eylea market. Ocular diseases are visual impairments that hinder proper eye function, impairing vision and clarity, and frequently manifest without symptoms until they reach advanced stages. Eylea is used to treat such eye conditions, specifically including wet age-related macular degeneration (AMD) and glaucoma, which cause damage to the retina or macula, consequently impacting vision. The medication, Eylea, works by inhibiting the protein responsible for the formation of new, fragile blood vessels and by reducing retinal swelling that results from blood vessel obstructions. For example, data from the BrightFocus Foundation, a U.S.-based nonprofit dedicated to macular degeneration and glaucoma research, indicates that in 2024, around 80 million individuals worldwide are affected by glaucoma, a figure expected to increase to 111 million by 2040. Consequently, the growing occurrence of ocular diseases is a primary factor fueling the Eylea market.

Which Segment-Based Categories Are Covered In The Eylea Market?

The eylea market covered in this report is segmented –

1) By Product: Prefilled Syringe Package, Vial Package

2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders

3) By Application: Hospitals, Retail Pharmacy, Other Applications

Subsegments:

1) By Prefilled Syringe Package: Single-Dose Prefilled Syringes, Multi-Dose Prefilled Syringes

2) By Vial Package: Single-Dose Vials, Multi-Dose Vials

Which Trends Are Influencing The Expansion Of The Eylea Market?

Leading companies in the eylea market are prioritizing the development of biologic medications like aflibercept biosimilar to gain a competitive advantage. An Aflibercept Biosimilar is a biologically similar version of the original drug aflibercept, engineered to have no clinically meaningful differences, thus offering a cost-effective treatment alternative for specific eye conditions. For example, in September 2023, Biocon Biologics Ltd., an India-based biopharmaceutical firm, received marketing authorization from the European Commission (EC) for YESAFILI, an Aflibercept biosimilar, within the European Union (EU). This approval follows a positive opinion issued by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in July. YESAFILI is an ophthalmology product designed for the treatment of various eye conditions, and its authorization confirms its comparability in terms of quality, safety, and efficacy to the reference product Eylea (aflibercept).

Who Are The Firms Contributing To The Eylea Market Ecosystem?

Major companies operating in the eylea market are Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Roche Holding AG, Pfizer Inc., Amgen Inc., Sanofi S.A., AbbVie Inc., Alcon Inc., Genentech Inc., Johnson & Johnson, Samsung Bioepis Co. Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Daiichi Sankyo Company Limited, Aerie Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Santen Pharmaceutical Co. Ltd., Allergan plc, BioMarin Pharmaceutical Inc.

Access The Complete Eylea Market Report:

https://www.thebusinessresearchcompany.com/report/eylea-global-market-report

What Is The Largest Regional Market In The Eylea Market?

North America was the largest region in the eylea market in 2025. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Eylea Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp

Browse Through More Reports Similar to the Global Eylea Market 2026, By The Business Research Company

Eylea Market Report 2026

https://www.thebusinessresearchcompany.com/report/eylea-global-market-report

Xylene Market Report 2026

https://www.thebusinessresearchcompany.com/report/xylene-global-market-report

Vanadium Market Report 2026

https://www.thebusinessresearchcompany.com/report/vanadium-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795